Anti-VZV gpII Recombinant Antibody (93KA9) (CAT#: MRO-1152LC)

This product is a recombinant human anti-Varicella-zoster virus monoclonal antibody. 93KA9 specifically binds to gpII associated with VZV and can be potentially used in the treatment and diagnosis of Varicella-zoster virus infection.

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Formats:

  • Isotype Switching:

  • Fc Engineering:

  • Modalities:

Custom Production

We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

Sequences:
Isotype :
Purity :
Endotoxin :
Quantity :
Conjugation :
Fc Engineering :
Modalities :
Other Requirements:
We require custom production
  • Published Data
  • Datasheet
  • MSDS
  • COA
Neut

Figure 1 Neutralization of VZV by 93KA9 antibody.

Figure 1 Neutralization of VZV by 93KA9 antibody.

The percentage cytopathic effect was estimated by microscopic visual examination of the infected cells (100%=total cell layer destruction, 0%=no visible cytopathic effect).

Human antibodies against varicella-zoster virus

ADCC

Figure 2 Antibody dependent cellular cytotoxicity (ADCC) of VZV-infected MRC-5 cells by anti-VZV gpII human monoclonal antibody 93KA9, compared with pooled human sera and an unrelated human monoclonal antibody control.

Figure 2 Antibody dependent cellular cytotoxicity (ADCC) of VZV-infected MRC-5 cells by anti-VZV gpII human monoclonal antibody 93KA9, compared with pooled human sera and an unrelated human monoclonal antibody control.

Human antibodies against varicella-zoster virus


Specifications

  • Host Species
  • Human
  • Type
  • Human antibody
  • Specificity
  • Varicella-zoster virus
  • Clone
  • 93KA9
  • Applications
  • ELISA, Neut, ADCC
  • Related Disease
  • Varicella-zoster virus infection

Applications

  • Application Notes
  • The VZV gpII antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Neutralization, Antibody-dependent Cell-mediated Cytotoxicity.

Target

  • Alternative Names
  • Varicella-zoster virus; VZV; Varicella-zoster virus glycoprotein II; VZV gpII

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 93KA9"

See other products for "VZV gpII"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products Humanized Antibody Products Human Antibody Products
CAT Product Name Application Type
MRO-1355CQ Recombinant Mouse Anti-VZV gpII Antibody (SG2-2E6) IF, IHC, IP, WB Mouse antibody
MRO-2699CQ Recombinant Mouse Anti-VZV gpII Antibody (MRO-2699CQ) WB, IP, IF Mouse antibody
FAMAB-0730WJ Human Anti-VZV gpII Recombinant Antibody (clone V1) ELISA, WB, Neut Human IgG

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for MRO-1152LC. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare